Day: January 8, 2025

Company Secures $20 Million Funding Commitment to Advance Aerospace & Defense InitiativesWEWAHITCHKA-PORT ST JOE, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) — UAV Corp. (OTC: UMAV), a leader in innovative manned and unmanned aerial vehicle (UAV) technologies, is pleased to announce an additional reduction in its authorized share count. Building upon the strategic reduction announced on December 16, 2024, the Company’s Board of Directors has approved a further decrease of 300 million authorized shares, lowering the total from 800 million to 500 million. This decision comes in response to shareholder support for the Company’s previous reduction, which saw a decrease of 1.2 billion shares, reducing the authorized share count from 2 billion to 800 million. The latest adjustment demonstrates UAV Corp.’s ongoing commitment to optimizing...

Company Sees Potential Surge in Air Purifier Sales as Southern California Wildfires Highlight Need for Clean Indoor Air Solutions Los Angeles, CA , Jan. 08, 2025 (GLOBE NEWSWIRE) — Los Angeles, CA – January 8, 2025 – KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a leader in innovation-driven air purification technology, announces expedited shipping and discounts on its home, school, and small business air purifier products and graphene face masks in response to the worsening wildfire conditions in Southern California. Wildfire Smoke Impacts Southern California Air Quality As wildfires rage across Southern California, local municipalities are issuing air quality alerts due to the dangerous levels of smoke pollution. The American Lung Association recently ranked Los Angeles-Long Beach as the most...

As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035 CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the Company and its licensor SERB S.A. (“SERB”) have entered into a Settlement Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. (collectively Teva). This Agreement resolves the patent litigation brought by Catalyst and SERB in response to Teva’s Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of FIRDAPSE®...

Completely Redesigned From Bow to Stern, The 23- and 25-Foot XStar Models Combine Legendary Performance With Cutting-Edge Innovation and Bold New Styling Upgrades Include New MAAX Audio, Z100 Tower, All-New 4 Camera Visibility System, Completely Redesigned Helm and Transom, Reimagined Design, Luxurious Interior and Standard Supercharged Engine VONORE, Tenn., Jan. 08, 2025 (GLOBE NEWSWIRE) — MasterCraft Boat Company, a MasterCraft Boat Holdings, Inc (NASDAQ: MCFT) subsidiary and the best-selling towboat brand, proudly announces the all-new XStar lineup, a groundbreaking evolution of its iconic flagship model. With a complete redesign spanning from bow to stern, the new XStar models introduce a fresh 23-foot model and an all-new 25-foot offering delivering unmatched attitude, luxurious amenities, and meticulous attention to detail....

Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) — Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced the closing of its initial public offering (the “Offering”) of 1,500,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and commenced trading on January 7, 2025 under the ticker symbol “ZYBT.” The Company received aggregate gross proceeds of $6 million from the Offering, before deducting underwriting discounts and other related expenses. Additionally, the Company has granted...

WILLIAMSVILLE, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) — National Fuel Gas Company (NYSE: NFG) today announced it will release its first quarter fiscal 2025 earnings results on Wednesday, January 29, 2025 after market close. A conference call to discuss the results will be held on Thursday, January 30, 2025 beginning at 10:00 a.m. ET. Prepared remarks from the executive team are planned for approximately 20 minutes followed by a question and answer session. All participants must pre-register to join this conference using the Participant Registration link. A webcast link to the conference call will be provided under the Events Calendar on the NFG Investor Relations website at investor.nationalfuelgas.com. A replay will be available following the call through the end of the day, Thursday, February 6, 2025. To access the replay, dial...

Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union Square NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) — Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s disease, announces that it will present at Biotech Showcase 2025, an event expected to include over 3,200 healthcare professionals with more than 1,200 investors. The event will be held at the Hilton Hotel in Union Square, San Francisco during the J.P. Morgan Healthcare Week, and KLTO’s Founder, CEO and Chairman, Dr. Joseph Sinkule, will give a presentation at 3:00 p.m. PT on Tuesday, January 14. Biotech Showcase 2025 Presentation Details:Date: Tuesday, January 14, 2025Time: 3:00 PM PTTrack: Yosemite-CWebcast...

Regulated informationParis, 8 January 2025Half-yearly report on the Orange liquidity contractAs part of the liquidity contract signed by Orange with Rothschild Martin Maurel, the following assets appeared on the liquidity account as of December 31, 2024:0 share € 50,026,203  Over the period from 2024-07-01 to 2024-12-31, a total of:  Number of transactions executed Volume exchanged Amount in €Buy side 6,123 11,123,066 112,476,576.52Sell side 8,375 12,018,066 121,588,603.80It is reminded that as of June 30, 2024 the following assets appeared on the liquidity account:895,000 shares € 40,771,311In addition, Orange publishes thereafter, for each trading day during the last 6 months of 2024, the number of transactions entered into as well as the volume of shares and the amount of equity purchased and sold.Date Number...